0
Northwest Biotherapeutics, Inc
- 11-50 Employees
- Based in Bethesda, Maryland
Northwest Biotherapeutics, Inc., a biotechnology company, discovers and develops immunotherapy products to treat cancer in the United States and internationally. It is involved in the development of DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer.
Social Media Links
Northwest Biotherapeutics, Inc
Most Recent Annual Report
Northwest Biotherapeutics, Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.
Please fill out the form below and click "Place Order" to complete your order.